Treatment for Advanced Tumors: Src Reclaims Center Stage

This publication has 43 references indexed in Scilit:

• Simultaneous Inhibition of EGFR, VEGFR, and Platelet-Derived Growth Factor Receptor Signaling Combined with Gemcitabine Produces Therapy of Human Pancreatic Carcinoma and Prolongs Survival in an Orthotopic Nude Mouse Model
  Cancer Research, 2005
• Dasatinib (BMS-354825) Tyrosine Kinase Inhibitor Suppresses Invasion and Induces Cell Cycle Arrest and Apoptosis of Head and Neck Squamous Cell Carcinoma and Non–Small Cell Lung Cancer Cells
  Clinical Cancer Research, 2005
• Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition
  Current Opinion in Cell Biology, 2005
• Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice
  The Prostate, 2005
• Tumor Cell and Endothelial Cell Therapy of Oral Cancer by Dual Tyrosine Kinase Receptor Blockade
  Cancer Research, 2004
• A renaissance for SRC
  Nature Reviews Cancer, 2004
• SRCgene expression in human cancer: the role of transcriptional activation
  Biochemistry and Cell Biology, 2004
• Activation of Src kinase in primary colorectal carcinoma
  Cancer, 2002
• CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
  Annual Review of Cell and Developmental Biology, 1997
• Src and the control of cell division
  BioEssays, 1996